Cellectar Biosciences, Inc. - Common Shares (CLRB)
CUSIP: 15117F880
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 4,338,395
- Total 13F shares
- 103,397
- Share change
- +103,397
- Total reported value
- $734,048
- Price per share
- $7.11
- Number of holders
- 19
- Value change
- +$734,048
- Number of buys
- 19
Quarterly Holders Quick Answers
What is CUSIP 15117F880?
CUSIP 15117F880 identifies CLRB - Cellectar Biosciences, Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2025
Recent filing periods for CUSIP 15117F880:
Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Orin Hirschman |
13D/G
|
— |
4.9%
|
2,022,221
|
$586,444 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
1,721,838
|
$542,379 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
2.1%
|
920,352
|
$289,911 | — | 31 Mar 2025 | |
| Laurence W. Lytton |
13D/G
|
LYTTON LAURENCE W |
1.6%
|
51,391
|
$250,788 | $0 | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
443,424
|
$139,842 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.85%
|
370,865
|
$116,934 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.78%
|
343,258
|
$108,229 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.53%
|
230,814
|
$72,776 | — | 31 Mar 2025 | |
| Sequoia Financial Advisors, LLC |
13F
|
Company |
0.46%
|
203,260
|
$64,088 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.4%
|
173,129
|
$54,000 | — | 31 Mar 2025 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
0.4%
|
172,940
|
$43,100 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.29%
|
128,114
|
$40,394 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.24%
|
104,323
|
$32,893 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
83,099
|
$26,201 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
77,988
|
$24,590 | — | 31 Mar 2025 | |
| Andrei Shustov |
3/4/5
|
Senior Vice President, Medical |
—
mixed-class rows
|
315,038
mixed-class rows
|
$15,411 | — | 14 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.11%
|
46,236
|
$14,000 | — | 31 Mar 2025 | |
| Rochester Wealth Strategies, LLC |
13F
|
Company |
0.1%
|
43,000
|
$13,558 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
13D/G
|
Company |
0.1%
from 13D/G
|
40,228
|
$12,684 | — | 31 Mar 2025 | |
| Darrell Shane Lea |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
299,599
mixed-class rows
|
$11,088 | — | 14 Jun 2024 | |
| Nordwand Advisors, LLC |
13F
|
Company |
0.05%
|
20,000
|
$6,306 | — | 31 Mar 2025 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.04%
|
17,587
|
$5,545 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13D/G
|
— |
0.06%
|
1,109
|
$5,412 | $0 | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
15,305
|
$4,826 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
12,051
|
$4,000 | — | 31 Mar 2025 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.03%
|
12,500
|
$3,941 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
10,807
|
$3,407 | — | 31 Mar 2025 | |
| COMMERCE BANK |
13F
|
Company |
0.02%
|
10,000
|
$3,153 | — | 31 Mar 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
1,646
|
$519 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
1,398
|
$441 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
921
|
$293 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
400
|
$126 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
347
|
$109 | — | 31 Mar 2025 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
100
|
$32 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
76
|
$24 | — | 31 Mar 2025 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
50
|
$16 | — | 31 Mar 2025 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0%
|
18
|
$6 | — | 31 Mar 2025 | |
| Dov Elefant |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
422,000
|
— | — | 25 Jan 2022 | |
| Douglas J. Swirsky |
3/4/5
|
Director |
—
class O/S missing
|
90,000
|
— | — | 14 Feb 2025 | |
| Asher Chanan-Khan |
3/4/5
|
Director |
—
class O/S missing
|
60,000
|
— | — | 14 Feb 2025 | |
| Frederick W. Driscoll |
3/4/5
|
Director |
—
class O/S missing
|
60,000
|
— | — | 14 Feb 2025 | |
| Stefan Loren |
3/4/5
|
Director |
—
class O/S missing
|
60,000
|
— | — | 14 Feb 2025 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q2 2025
As of 30 Jun 2025,
Cellectar Biosciences, Inc. - Common Shares (CLRB) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,397 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, Riverview Capital Advisers, LLC, BlackRock, Inc., UBS Group AG, MORGAN STANLEY, SIMPLEX TRADING, LLC, Tower Research Capital LLC (TRC), and RAYMOND JAMES FINANCIAL INC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q3 2025 Across Filers
Q3 2025 holders
21
Q2 2025 holders
19
Holder diff
-2
| Investor | Q3 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.